Bill
Bill > H1115
MA H1115
Relative to the care and treatment of patients with mitochondrial disease
summary
Introduced
01/22/2019
01/22/2019
In Committee
01/22/2019
01/22/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
Relative to insurance coverage and payment for prescribed treatment for mitochondrial disease. Financial Services.
AI Summary
This bill requires insurance coverage and payment for prescribed treatment of mitochondrial disease, including the use of specific vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. The bill amends several chapters of the Massachusetts General Laws to mandate this coverage for active and retired state employees, as well as those with individual or group health insurance policies, hospital service plans, medical service agreements, and health maintenance contracts issued or renewed in the Commonwealth.
Committee Categories
Business and Industry
Sponsors (18)
Jim Arciero (D),
Mark Cusack (D),
Michelle DuBois (D),
Sean Garballey (D),
Colleen Garry (D),
Carlos González (D),
Jim Hawkins (D),
Chris Hendricks (D),
Louis Kafka (D),
Patrick Kearney (D),
Kay Khan (D),
Joe McGonagle (D),
Christina Minicucci (D),
Becca Rausch (D),
John Rogers (D),
Tom Stanley (D),
José Tosado (D),
Steve Ultrino (D),
Last Action
Accompanied a study order, see H5160 (on 12/01/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/H1115 |
| Bill | https://malegislature.gov/Bills/191/H1115.pdf |
Loading...